Non-alcoholic fatty liver disease (NAFLD) has now become the leading chronic liver disease
worldwide with lifestyle changes. This may lead to NAFLD becoming the leading cause of …

Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype
nonalcoholic steatohepatitis (NASH), have emerged as significant contributors to hepatic …

Obesity is a prevalent predisposing factor to non-alcoholic fatty liver disease (NAFLD), the
most common chronic liver disease in the developed world. NAFLD spectrum of disease …

Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the metabolic
syndrome. NAFLD constitutes a spectrum of pathologies ranging from simple hepatic …

The liver is the site of first pass metabolism, detoxifying and metabolizing blood arriving from
the hepatic portal vein and hepatic artery. It is made up of multiple cell types, including …

Introduction Nonalcoholic fatty liver disease (NAFLD) is considered the hepatic
manifestation of the metabolic syndrome and is rapidly emerging as the leading cause of …

Non-alcoholic fatty liver disease (NAFLD) causes significant global disease burden and is a
leading cause of mortality. NAFLD induces a myriad of aberrant changes in hepatocytes at …

Non-alcoholic fatty liver disease (NAFLD) exhibits increased lipid enrichment in
hepatocytes. The spectrum of this disease includes stages such as nonalcoholic simple fatty …

Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease
worldwide, both in adults and children. It is characterized by an aberrant lipid storage in …

Nonalcoholic fatty liver disease (NAFLD), recently renamed as metabolic (dysfunction)-
associated fatty liver disease (MAFLD), is a complex, multifactorial disease that progresses …